EUVIMEDEUVIMED entdecken
Crossref

PATZ1 Immunohistochemistry Aids in the Diagnosis of PATZ1-Rearranged Sarcomas

Melissa S Gildenberg, Andrew L Folpe, Gregory W Charville, Yin P Hung, Jason L Hornick, William J Anderson

Modern Pathology · 2026

DOI: 10.1016/j.modpat.2026.101021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Melissa S Gildenberg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Sarcoma, Immunohistochemistry, Biomarkers, Tumor, Gene Rearrangement. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PATZ1-rearranged sarcomas are diagnostically challenging due to their rather non-specific morphology and immunophenotype. These tumors are characterized by bland, round-to-spindled cells within a fibromyxoid matrix with variable microcysts, fibrous septa, hyalinized vessels, and cellular whorls. PATZ1-rearranged sarcomas are often positive for neural, skeletal muscle, and epithelial markers. Identification of these tumors is further complicated by the cryptic nature of the characteristic EWSR1::PATZ1 fusion, which generally makes fluorescence in situ hybridization analysis unreliable if rearrangement is not detected. As a result, costly and time-intensive molecular assays are often currently necessary for definitive diagnosis. The purpose of this study was to assess immunohistochemistry (IHC) for PATZ1 as a surrogate for detecting the gene fusion. In total, 533 tumors from whole-tissue sections and tissue microarrays were evaluated, including 14 PATZ1-rearranged sarcomas as well as other benign and malignant mesenchymal neoplasms. IHC for PATZ1 was positive in 12/14 (86%) PATZ1-rearranged sarcomas. Of the remaining tumor types, 495 (95%) were negative for PATZ1. Notably, PATZ1 expression was observed in a subset of other tumor types, including myoepithelial carcinoma (2/4; 50%), myoepithelioma (2/15; 13%), rhabdomyosarcoma (RMS) (13/99; 13%), desmoplastic small round cell tumor (1/10; 10%), dermatofibrosarcoma protuberans (1/10; 10%), myxoid liposarcoma (1/16; 6%), schwannoma (1/22; 5%), and malignant peripheral nerve sheath tumor (3/70; 4%). The 13 RMS cases that were positive were classified as embryonal (n = 7), alveolar (n = 5), and RMS, not otherwise specified (n = 1). In conclusion, PATZ1 IHC is moderately sensitive and specific for PATZ1-rearranged sarcomas, and it may be a helpful diagnostic marker for this challenging tumor. Although most tumors with morphologic overlap with PATZ1-rearranged sarcomas are negative for PATZ1 by IHC, expression in a subset of myoepithelial tumors and RMS represents a potential diagnostic pitfall.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaImmunohistochemistryBiomarkers, TumorGene RearrangementRepressor ProteinsSoft Tissue NeoplasmsHumansFemaleIn Situ Hybridization, FluorescenceTissue Array AnalysisKruppel-Like Transcription Factors

Stichwörter der Autor:innen

EWSR1PATZ1Sarcoma

Substanzen

Biomarkers, TumorPATZ1 protein, humanRepressor ProteinsKruppel-Like Transcription Factors

Autor:innen und Institutionen

  • Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Department of Pathology, Stanford University, Stanford, California.
  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: wanderson@bwh.harvard.edu.

Zitieren

APA

Gildenberg, M. S., Folpe, A. L., Charville, G. W., Hung, Y. P., Hornick, J. L., & Anderson, W. J. (2026). PATZ1 Immunohistochemistry Aids in the Diagnosis of PATZ1-Rearranged Sarcomas. Modern Pathology. https://doi.org/10.1016/j.modpat.2026.101021

Vancouver

Gildenberg MS, Folpe AL, Charville GW, Hung YP, Hornick JL, Anderson WJ. PATZ1 Immunohistochemistry Aids in the Diagnosis of PATZ1-Rearranged Sarcomas. Modern Pathology. 2026. doi:10.1016/j.modpat.2026.101021

BibTeX
@article{Gildenberg2026,
  author = {Gildenberg, Melissa S and Folpe, Andrew L and Charville, Gregory W and Hung, Yin P and Hornick, Jason L and Anderson, William J},
  title = {PATZ1 Immunohistochemistry Aids in the Diagnosis of PATZ1-Rearranged Sarcomas},
  journal = {Modern Pathology},
  year = {2026},
  doi = {10.1016/j.modpat.2026.101021}
}
Kostenlos starten →